Blueprint Medicines (BPMC) PT Lowered to $105 at Morgan Stanley

February 18, 2021 2:58 AM EST
Get Alerts BPMC Hot Sheet
Price: $92.58 --0%

Rating Summary:
    13 Buy, 6 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 19 | Down: 23 | New: 31
Trade Now! 
Join SI Premium – FREE
Morgan Stanley analyst David Lebowitz lowered the price target on Blueprint Medicines (NASDAQ: BPMC) to $105.00 (from $112.00) while maintaining a Equalweight rating.

You May Also Be Interested In





Related Categories

Analyst PT Change